IL17A and demyelinating disease: One of the proposed mechanisms involve modulation of the DC compartment, since Lgals3−/− DCs inhibit the production of IL-17 when co-cultured with T cells, suggesting that this chimera-type lectin exacerbates demyelinating disease by augmenting IL-17 and IFN-γ synthesis and decreasing IL-10 production [144].